What We Believe

Complex conditions like COPD are incredibly challenging to manage. People who are already struggling with isolation and the burden of multiple comorbidities become increasingly frustrated and disengaged, eventually falling through the cracks. This perpetuates poor outcomes and excessive costs. NuvoAir embraces the challenges that others can’t or won’t. We integrate the best of human-led care, connected devices and disruptive technology to break the cycle of disconnection and failure in clinical care and trial settings. NuvoAir: Taking Care of Complexity

... ...
...
...
...
...

Headquartered in Boston, MA with a European office in Stockholm, Sweden

NuvoAir is a digital health company focusing on patients living with COPD and CHF, and asthma. NuvoAir offers a virtual-first care (V1C) solution that delivers continuous, proactive care by combining best-in-class remote monitoring technology with proprietary biomarkers, deep clinical expertise, and a data-driven infrastructure.

NuvoAir works with risk-bearing partners to integrate technology and data to enable personalized care for each member. Our patient-centric approach also underlies our clinical trials solution.

Our Partners

Hospitals, universities, pharma companies and CROs around the world have chosen NuvoAir as their respiratory partner. We’re proud to support the work of forward-thinking, innovative players and researchers.

Seattle Children's Hospital
Roche
HNS Royal Brompton & Harefield
Regeneron
Novartis
NHS King's College Hospital
Dartmouth-Hitchcock
InterMedCon Gmbh
University os Ioannina
Boston Children's Hospital